BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Clinical trial NCT07755904 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07755904
Sponsor: Braveheart Bio, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiomyopathy, Hypertrophic Obstructive

Start date: 2026-10-01
Primary completion: 2028-10-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.